TNFRSF9 and cancer: Since DSP107 potently triggered 4-1BB costimulatory signaling, its effect on T cell-mediated killing of cancer cells was assessed by co-culture of isolated CD3+, CD4+, or CD8+ T cells with the CD47-positive NHL line SC-1.scFvCD3.